All reports
Public comment
Prescription Drug Machine-Readable File
Drug pricing policy
Price transparency regulations
Transparency compliance

Turquoise's public comment on CMS-9882-NC

Turquoise's public comment on CMS-9882-NC

Turquoise Health is in full support of the Departments' commitment to broadening price transparency requirements to include prescription drugs. Transparency is ultimately about reducing the financial complexity of healthcare and creating an ecosystem that allows patients to shop for care in advance. Transparent reporting of prescription drug rates is a critical step in building infrastructure that enables patients to receive a comprehensive cost of care before an appointment occurs.

Download PDF

Related resources

Learn, listen, and watch the latest on price transparency.

View all
Turquoise's Public Comment on CMS-1850-P
Public comment
8/25/26

Turquoise's Public Comment on CMS-1850-P

Turquoise's public comments to CMS on the CY 2027 OPPS/ASC proposed rule: a JSON MRF schema, bundled shoppable services, and 340B impacts by hospital type.

Turquoise's public comment on CMS 9882-P
Transparency in Coverage (TiC)
2/23/26

Turquoise's public comment on CMS 9882-P

Transparency in Coverage files are on the verge of a much-needed overhaul to become leaner, more organized, and more useful.

Turquoise's public comment on CMS-1834-P
Public comment
9/15/25

Turquoise's public comment on CMS-1834-P

Turquoise Health's public comment on CMS-1834-P supporting comprehensive hospital MRF standards, seeking clarification on new percentile fields, and providing recommendations on EDI 835 ERA transaction data utility. Read our full analysis.